Primary Media
We develop programmable therapeutic platforms that combine biomaterials, vesicle engineering, cell-free systems, synthetic biology, and design-build-test-learn workflows. The platforms are translated to address urgent needs in various biomedical fields, including biomanufacturing, immunotherapy, chronic disease therapy, and regeneration.
Launch Date
Live site url